My Quote Request
No products added yet
6505-01-381-6421
20 Products
NDC63323-0173-02
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505013816421
NSN
6505-01-381-6421
NDC63323-0173-02
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505013816421
NSN
6505-01-381-6421
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP 10MG/ML 2ML BT 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC39769-0001-02
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505013816421
NSN
6505-01-381-6421
NDC39769-0001-02
GENTAMICIN SULFATE INJECTION,USP
NSN, MFG P/N
6505013816421
NSN
6505-01-381-6421
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS GENTAMICIN EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE INJECTION USP 10MG/ML 2ML BT 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00024-1401-51
IOHEXOL INJECTION
NSN, MFG P/N
6505013819506
NSN
6505-01-381-9506
MFG
SANOFI-SYNTHELABO INC
Description
IOHEXOL INJECTION
Related Searches:
OMINIPAQUE 140
IOHEXOL INJECTION
NSN, MFG P/N
6505013819506
NSN
6505-01-381-9506
MFG
SANOFI-SYNTHELABO INC
Description
IOHEXOL INJECTION
Related Searches:
Y550
IOHEXOL INJECTION
NSN, MFG P/N
6505013819506
NSN
6505-01-381-9506
MFG
SANOFI-SYNTHELABO INC
Description
IOHEXOL INJECTION
Related Searches:
A93G019
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
A93G019
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: HEPARIN 1000 U IN 0.9% SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00264-9872-10
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
NDC00264-9872-10
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
MFG
B BRAUN MEDICAL INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: HEPARIN 1000 U IN 0.9% SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
P8721
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
P8721
HEPARIN SODIUM IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505013820098
NSN
6505-01-382-0098
MFG
B BRAUN MEDICAL INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: HEPARIN 1000 U IN 0.9% SODIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
ENTERO-H
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505013820156
NSN
6505-01-382-0156
ENTERO-H
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505013820156
NSN
6505-01-382-0156
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1900.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PLEASANT TASTING; DISPENSE UNDILUTED FOR DOUBLE CONTRAST PROCEDURES AND DILUTED FOR SINGLE CONTRAST STUDIES; USED PRIMARILY AS A CONTRAST MEDIUM IN ENTEROCLYSIS
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
L147
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505013820156
NSN
6505-01-382-0156
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1900.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PLEASANT TASTING; DISPENSE UNDILUTED FOR DOUBLE CONTRAST PROCEDURES AND DILUTED FOR SINGLE CONTRAST STUDIES; USED PRIMARILY AS A CONTRAST MEDIUM IN ENTEROCLYSIS
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 50ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,50 ML BOTTLE;THPE TO LORABID BY ELI-LILY;FOR ANTIBIOTIC USE
Related Searches:
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 50ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,50 ML BOTTLE;THPE TO LORABID BY ELI-LILY;FOR ANTIBIOTIC USE
Related Searches:
NDC00247-0855-50
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
NDC00247-0855-50
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822790
NSN
6505-01-382-2790
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 50ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,50 ML BOTTLE;THPE TO LORABID BY ELI-LILY;FOR ANTIBIOTIC USE
Related Searches:
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT
SPECIAL FEATURES: 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE
Related Searches:
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT
SPECIAL FEATURES: 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE
Related Searches:
NDC00002-5136-48
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
NDC00002-5136-48
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822804
NSN
6505-01-382-2804
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 200MG/5ML 100ML BT
SPECIAL FEATURES: 200 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTOBIOTIC USE
Related Searches:
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
LORABID
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 100ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTIBIOTIC USE
Related Searches:
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
LORABID FOR ORAL SUSPENSION
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 100ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTIBIOTIC USE
Related Searches:
NDC00002-5135-48
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
NDC00002-5135-48
LORACARBEF FOR ORAL SUSPENSION
NSN, MFG P/N
6505013822808
NSN
6505-01-382-2808
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORACARBEF FOR ORAL SUSPENSION 100MG/5ML 100ML BT
SPECIAL FEATURES: 100 MG LORACARBEF PER 5 ML,100 ML BOTTLE;THPE TO LORABID BY ELI-LILY;LYOPHILIZED POWDER;FOR ANTIBIOTIC USE
Related Searches:
NDC00008-0690-01
KETOPROFEN CAPSULES
NSN, MFG P/N
6505013824325
NSN
6505-01-382-4325
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS KETOPROFEN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOPROFEN CAPSULES 200MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: FOR USE AS NONSTEROIDAL ANTI-INFLAMMATORY
THERAPEUTIC EQUIVALENT: ORUVAIL BY WYETH-AYERST LABS
